ZNF45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.220210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.605200E-01
Normal-vs-Stage2
1.116830E-01
Normal-vs-Stage3
8.067600E-02
Normal-vs-Stage4
7.468200E-01
Stage1-vs-Stage2
1.784630E-01
Stage1-vs-Stage3
6.599600E-02
Stage1-vs-Stage4
8.576200E-01
Stage2-vs-Stage3
1.873640E-01
Stage2-vs-Stage4
1.822770E-01
Stage3-vs-Stage4
1.988080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.205240E-01
Normal-vs-AfricanAmerican
4.650000E-01
Normal-vs-Asian
9.625900E-02
Caucasian-vs-AfricanAmerican
4.803600E-01
Caucasian-vs-Asian
4.038000E-01
AfricanAmerican-vs-Asian
2.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.062570E-01
Normal-vs-Female
1.647210E-01
Male-vs-Female
4.694200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.708600E-01
Normal-vs-Age(41-60Yrs)
3.299400E-01
Normal-vs-Age(61-80Yrs)
7.474000E-02
Normal-vs-Age(81-100Yrs)
4.461600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.534600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.195830E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.362400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.021100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.762300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.967900E-02
Normal-vs-Daily Drinker
3.177900E-02
Normal-vs-Weekly Drinker
8.503800E-02
Normal-vs-Occasional Drinker
2.568600E-01
Normal-vs-Social Drinker
2.381800E-01
Non Drinker-vs-Daily Drinker
9.078600E-01
Non Drinker-vs-Weekly Drinker
7.818000E-01
Non Drinker-vs-Occasional Drinker
6.505500E-02
Non Drinker-vs-Social Drinker
1.314620E-01
Daily Drinker-vs-Weekly Drinker
7.095400E-01
Daily Drinker-vs-Occasional Drinker
5.717700E-02
Daily Drinker-vs-Social Drinker
1.142840E-01
Weekly Drinker-vs-Occasional Drinker
1.921950E-01
Weekly Drinker-vs-Social Drinker
2.956400E-01
Occasional Drinker-vs-Social Drinker
8.370000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.363250E-01
Normal-vs-Grade 2
3.722400E-02
Normal-vs-Grade 3
4.067600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.597000E-01
Grade 1-vs-Grade 3
9.249200E-01
Grade 1-vs-Grade 4
1.363250E-01
Grade 2-vs-Grade 3
4.030600E-01
Grade 2-vs-Grade 4
3.722400E-02
Grade 3-vs-Grade 4
4.067600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.711740E-02
Normal-vs-NonDiabetic
9.234400E-02
Diabetic-vs-NonDiabetic
7.401900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.094210E-01
Normal-vs-NoPancreatitis
6.552400E-02
Pancreatitis-vs-NoPancreatitis
5.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.166400E-01
Normal-vs-N1
9.908000E-02
N0-vs-N1
5.521800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.232400E-01
Normal-vs-TP53-NonMutant
4.683800E-01
TP53-Mutant-vs-TP53-NonMutant
5.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
